- Home
- TXMD vs SIGIP Comparison
TXMD vs SIGIP Comparison
Compare TXMD & SIGIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- SIGIP
- Stock Information
- Founded
- TXMD 2008
- SIGIP N/A
- Country
- TXMD United States
- SIGIP United States
- Employees
- TXMD N/A
- SIGIP 2800
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- SIGIP Property-Casualty Insurers
- Sector
- TXMD Health Care
- SIGIP Finance
- Exchange
- TXMD Nasdaq
- SIGIP Nasdaq
- Market Cap
- TXMD 12.8M
- SIGIP N/A
- IPO Year
- TXMD N/A
- SIGIP N/A
- Fundamental
- Price
- TXMD $1.19
- SIGIP $17.11
- Analyst Decision
- TXMD
- SIGIP
- Analyst Count
- TXMD 0
- SIGIP 0
- Target Price
- TXMD N/A
- SIGIP N/A
- AVG Volume (30 Days)
- TXMD 44.6K
- SIGIP N/A
- Earning Date
- TXMD 08-11-2025
- SIGIP N/A
- Dividend Yield
- TXMD N/A
- SIGIP N/A
- EPS Growth
- TXMD N/A
- SIGIP N/A
- EPS
- TXMD N/A
- SIGIP N/A
- Revenue
- TXMD $1,841,000.00
- SIGIP N/A
- Revenue This Year
- TXMD $427.09
- SIGIP N/A
- Revenue Next Year
- TXMD N/A
- SIGIP N/A
- P/E Ratio
- TXMD N/A
- SIGIP N/A
- Revenue Growth
- TXMD 53.55
- SIGIP N/A
- 52 Week Low
- TXMD $0.70
- SIGIP N/A
- 52 Week High
- TXMD $2.44
- SIGIP N/A
- Technical
- Relative Strength Index (RSI)
- TXMD 49.81
- SIGIP 57.62
- Support Level
- TXMD $0.98
- SIGIP $16.79
- Resistance Level
- TXMD $1.21
- SIGIP $17.00
- Average True Range (ATR)
- TXMD 0.09
- SIGIP 0.14
- MACD
- TXMD 0.01
- SIGIP 0.04
- Stochastic Oscillator
- TXMD 82.48
- SIGIP 100.00
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About SIGIP Selective Insurance Group Inc. Depositary Shares each representing a 1/1000th interest in a share of 4.60% Non-Cumulative Preferred Stock Series B
Selective Insurance Group Inc is a regional property-casualty insurer based in New Jersey, with its operations focused in the New York metropolitan area. The Company has four operating segments: Standard Commercial Lines, Standard Personal Lines, E&S Lines, Investments. Majority of revenue is gained from Standard Personal Lines. Currently company has it's revenues from States of USA and Columbia.